255 related articles for article (PubMed ID: 38474224)
21. Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription.
Chen Y; Zhou K; Wang R; Liu Y; Kwak YD; Ma T; Thompson RC; Zhao Y; Smith L; Gasparini L; Luo Z; Xu H; Liao FF
Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3907-12. PubMed ID: 19237574
[TBL] [Abstract][Full Text] [Related]
22. Metformin induces apoptosis through AMPK-dependent inhibition of UPR signaling in ALL lymphoblasts.
Leclerc GM; Leclerc GJ; Kuznetsov JN; DeSalvo J; Barredo JC
PLoS One; 2013; 8(8):e74420. PubMed ID: 24009772
[TBL] [Abstract][Full Text] [Related]
23. Metformin prevents the pathological browning of subcutaneous white adipose tissue.
Auger C; Knuth CM; Abdullahi A; Samadi O; Parousis A; Jeschke MG
Mol Metab; 2019 Nov; 29():12-23. PubMed ID: 31668383
[TBL] [Abstract][Full Text] [Related]
24. Metformin and HER2-positive breast cancer: Mechanisms and therapeutic implications.
Bashraheel SS; Kheraldine H; Khalaf S; Moustafa AA
Biomed Pharmacother; 2023 Jun; 162():114676. PubMed ID: 37037091
[TBL] [Abstract][Full Text] [Related]
25. The antidiabetic drug metformin inhibits uterine leiomyoma cell proliferation via an AMP-activated protein kinase signaling pathway.
Li B; Takeda T; Tsuiji K; Kondo A; Kitamura M; Wong TF; Yaegashi N
Gynecol Endocrinol; 2013 Jan; 29(1):87-90. PubMed ID: 22835064
[TBL] [Abstract][Full Text] [Related]
26. Activation of AMP-activated Protein Kinase by Metformin Induces Protein Acetylation in Prostate and Ovarian Cancer Cells.
Galdieri L; Gatla H; Vancurova I; Vancura A
J Biol Chem; 2016 Nov; 291(48):25154-25166. PubMed ID: 27733682
[TBL] [Abstract][Full Text] [Related]
27. Metformin inhibits esophagus cancer proliferation through upregulation of USP7.
Xu Y; Lu S
Cell Physiol Biochem; 2013; 32(5):1178-86. PubMed ID: 24335168
[TBL] [Abstract][Full Text] [Related]
28. Current understanding of metformin effect on the control of hyperglycemia in diabetes.
An H; He L
J Endocrinol; 2016 Mar; 228(3):R97-106. PubMed ID: 26743209
[TBL] [Abstract][Full Text] [Related]
29. Metformin's Effects on Apoptosis of Esophageal Carcinoma Cells and Normal Esophageal Epithelial Cells: An In Vitro Comparative Study.
Peng J; Jing X; Wu J; Hong D; Hu X; Wang Q; Hu H; Cai X
Biomed Res Int; 2020; 2020():1068671. PubMed ID: 32258099
[TBL] [Abstract][Full Text] [Related]
30. The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases.
Hasanvand A
Inflammopharmacology; 2022 Jun; 30(3):775-788. PubMed ID: 35419709
[TBL] [Abstract][Full Text] [Related]
31. Metformin and Prostate Cancer: a New Role for an Old Drug.
Whitburn J; Edwards CM; Sooriakumaran P
Curr Urol Rep; 2017 Jun; 18(6):46. PubMed ID: 28444639
[TBL] [Abstract][Full Text] [Related]
32. Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer.
Schuler KM; Rambally BS; DiFurio MJ; Sampey BP; Gehrig PA; Makowski L; Bae-Jump VL
Cancer Med; 2015 Feb; 4(2):161-73. PubMed ID: 25417601
[TBL] [Abstract][Full Text] [Related]
33. Regulation of metformin response by breast cancer associated gene 2.
Buac D; Kona FR; Seth AK; Dou QP
Neoplasia; 2013 Dec; 15(12):1379-90. PubMed ID: 24403860
[TBL] [Abstract][Full Text] [Related]
34. Targeting BCAA metabolism to potentiate metformin's therapeutic efficacy in the treatment of diabetes in mice.
Zhao X; Zhang X; Pei J; Liu Y; Niu W; Sun H
Diabetologia; 2023 Nov; 66(11):2139-2153. PubMed ID: 37581618
[TBL] [Abstract][Full Text] [Related]
35. Metformin: taking away the candy for cancer?
Jalving M; Gietema JA; Lefrandt JD; de Jong S; Reyners AK; Gans RO; de Vries EG
Eur J Cancer; 2010 Sep; 46(13):2369-80. PubMed ID: 20656475
[TBL] [Abstract][Full Text] [Related]
36. Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.
Markowicz-Piasecka M; Sikora J; Szydłowska A; Skupień A; Mikiciuk-Olasik E; Huttunen KM
Pharm Res; 2017 Dec; 34(12):2614-2627. PubMed ID: 28589443
[TBL] [Abstract][Full Text] [Related]
37. DEPTOR-related mTOR suppression is involved in metformin's anti-cancer action in human liver cancer cells.
Obara A; Fujita Y; Abudukadier A; Fukushima T; Oguri Y; Ogura M; Harashima S; Hosokawa M; Inagaki N
Biochem Biophys Res Commun; 2015 May; 460(4):1047-52. PubMed ID: 25843797
[TBL] [Abstract][Full Text] [Related]
38. Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-β and p38/ERK MAPK signalling.
Ruiz-Mitjana A; Vidal-Sabanés M; Navaridas R; Perramon-Güell A; Yeramian A; Nicholson-Sabaté N; Egea J; Encinas M; Matias-Guiu X; Dolcet X
Biomed Pharmacother; 2023 Dec; 168():115817. PubMed ID: 37925934
[TBL] [Abstract][Full Text] [Related]
39. Metformin's Impact on the Microvascular Response to Insulin.
Love KM; Barrett EJ; Horton WB
Endocrinology; 2022 Oct; 163(11):. PubMed ID: 36201598
[TBL] [Abstract][Full Text] [Related]
40. Roles of Nuclear Receptors in Esophageal Cancer.
Deng L; Liu J; Chen WD; Wang YD
Curr Pharm Biotechnol; 2023; 24(12):1489-1503. PubMed ID: 36740804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
